CA2404127A1 - Recepteur de la gonadoliberine de type ii et polynucleotides codant pour ce recepteur - Google Patents

Recepteur de la gonadoliberine de type ii et polynucleotides codant pour ce recepteur Download PDF

Info

Publication number
CA2404127A1
CA2404127A1 CA002404127A CA2404127A CA2404127A1 CA 2404127 A1 CA2404127 A1 CA 2404127A1 CA 002404127 A CA002404127 A CA 002404127A CA 2404127 A CA2404127 A CA 2404127A CA 2404127 A1 CA2404127 A1 CA 2404127A1
Authority
CA
Canada
Prior art keywords
gnrh
type
leu
ala
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002404127A
Other languages
English (en)
Inventor
Robert Peter Millar
Steven Lowe
Darrell Conklin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0009269A external-priority patent/GB0009269D0/en
Priority claimed from GB0014761A external-priority patent/GB0014761D0/en
Application filed by Individual filed Critical Individual
Publication of CA2404127A1 publication Critical patent/CA2404127A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des polynucléotides codant la totalité de la séquence pour les récepteurs de la gonadolibérine de type II (GnRH-R de type II) apparaissant chez l'homme et les marmousets. L'invention se rapporte également aux séquences d'acides aminés correspondantes.
CA002404127A 2000-04-15 2001-04-17 Recepteur de la gonadoliberine de type ii et polynucleotides codant pour ce recepteur Abandoned CA2404127A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0009269.2 2000-04-15
GB0009269A GB0009269D0 (en) 2000-04-15 2000-04-15 Receptor
GB0014761A GB0014761D0 (en) 2000-06-17 2000-06-17 Receptor
GB0014761.2 2000-06-17
US21523200P 2000-06-30 2000-06-30
US60/215,232 2000-06-30
PCT/GB2001/001755 WO2001078796A1 (fr) 2000-04-15 2001-04-17 Recepteur de la gonadoliberine de type ii et polynucleotides codant pour ce recepteur

Publications (1)

Publication Number Publication Date
CA2404127A1 true CA2404127A1 (fr) 2001-10-25

Family

ID=27255670

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002404127A Abandoned CA2404127A1 (fr) 2000-04-15 2001-04-17 Recepteur de la gonadoliberine de type ii et polynucleotides codant pour ce recepteur

Country Status (11)

Country Link
EP (1) EP1337282A2 (fr)
JP (1) JP2003530837A (fr)
KR (1) KR20020097218A (fr)
AU (1) AU2001248599A1 (fr)
BR (1) BR0110098A (fr)
CA (1) CA2404127A1 (fr)
HU (1) HUP0301666A2 (fr)
IL (1) IL152011A0 (fr)
NO (1) NO20024937L (fr)
PL (1) PL357684A1 (fr)
WO (1) WO2001078796A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000701A2 (fr) * 2000-06-26 2002-01-03 Bayer Aktiengesellschaft Regulation du recepteur humain couple a la proteine g semblable au recepteur de l'hormone liberant la gonadotropine
WO2002070701A2 (fr) * 2001-03-01 2002-09-12 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Nouveau recepteur gnrh humain
US20050282745A1 (en) * 2001-08-28 2005-12-22 Siler-Khodr Theresa M Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
WO2004009636A2 (fr) * 2002-07-22 2004-01-29 Ardana Bioscience Limited Modulateur de la gnrh
DK1512016T3 (da) 2002-07-22 2006-07-03 Ardana Bioscience Ltd Screeningsmetode og antitumor-medikamentkandidat opnået derved
AU2003248955A1 (en) * 2002-07-22 2004-02-09 Ardana Bioscience Limited Screening method
KR101038183B1 (ko) * 2010-12-27 2011-06-01 강범준 조립식 파형블록과 이를 이용한 호안 경사면 피복방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000590A1 (fr) * 1992-06-23 1994-01-06 The Mt. Sinai School Of Medicine Of The City University Of New York CLONAGE ET EXPRESSION D'UN RECEPTEUR D'HORMONE LIBERANT DE LA GONADOTROPINE (R-HLGn)
WO1997047743A1 (fr) * 1996-06-13 1997-12-18 Zymogenetics, Inc. Recepteur humain de l'hormone de liberation de la gonadotrophine de type ii

Also Published As

Publication number Publication date
HUP0301666A2 (hu) 2003-08-28
WO2001078796A9 (fr) 2002-02-28
NO20024937L (no) 2002-12-09
PL357684A1 (en) 2004-07-26
EP1337282A2 (fr) 2003-08-27
WO2001078796A3 (fr) 2003-04-24
NO20024937D0 (no) 2002-10-14
IL152011A0 (en) 2003-04-10
WO2001078796A1 (fr) 2001-10-25
JP2003530837A (ja) 2003-10-21
KR20020097218A (ko) 2002-12-31
BR0110098A (pt) 2003-01-14
AU2001248599A1 (en) 2001-10-30

Similar Documents

Publication Publication Date Title
Millar et al. A novel mammalian receptor for the evolutionarily conserved type II GnRH
US6420532B1 (en) Method of obtaining compositions comprising Y2 specific compounds
JPH10510709A (ja) 摂食行動を変える方法、該方法に有用な化合物、および視床下部の異型神経ペプチドｙ／ペプチドｙｙ受容体（ｙ５）をコードするｄｎａ
JP4472256B2 (ja) ウロコルチンｉｉｉ及びその利用
US20050221436A1 (en) Human neuropeptide Y-like G protein-coupled receptor
EP0769024B1 (fr) Yrecepteurs de la melatonine de haute affinite et leurs utilisations
CA2404127A1 (fr) Recepteur de la gonadoliberine de type ii et polynucleotides codant pour ce recepteur
US6399315B1 (en) Screening assays using cloned CRF receptors
US6274333B1 (en) Type-2 neurotensin receptor (NT-R2)
US6482608B1 (en) Cloning and recombinant production of CRF receptor(S)
US20030166561A1 (en) Peptide
US20030124585A1 (en) Type II gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
US20020032322A1 (en) Family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs
US7666994B2 (en) Cloning and expression of gonadotropin-releasing hormone (GnRH) receptors
DE69930873T2 (de) Dna-moleküle kodierende spleissvarianten des humanen melanocortin-1-rezeptorproteins
JP2003527302A (ja) 新規な神経ペプチドレセプターｈｆｇａｎ７２のリガンドおよびそのアゴニストまたはアンタゴニストを用いる治療方法
US20030050434A1 (en) Peptide
US7081349B1 (en) High-affinity melatonin receptor and uses thereof
AU721053B2 (en) Cloning and recombinant production of CRF receptor(s)
Wei et al. [d-Pro5] Corticotropin-releasing factor analogs as selective agonists at corticotropin-releasing factor receptors
Usui et al. Characterization and distribution of an arginine vasotocin receptor in mouse
JP2004511202A (ja) ５−ｈｔ３セロトニン受容体のヒトサブユニットをコードするｄｎａ
US20030139589A1 (en) G protein coupled receptor A4
De Souza et al. 36. Overview of Corticotropin-Releasing Factor Receptors and Binding Protein

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20050418